Alison Long

1.0k total citations
19 papers, 624 citations indexed

About

Alison Long is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Alison Long has authored 19 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Alison Long's work include Virus-based gene therapy research (5 papers), Hemophilia Treatment and Research (4 papers) and CAR-T cell therapy research (3 papers). Alison Long is often cited by papers focused on Virus-based gene therapy research (5 papers), Hemophilia Treatment and Research (4 papers) and CAR-T cell therapy research (3 papers). Alison Long collaborates with scholars based in United States, United Kingdom and Netherlands. Alison Long's co-authors include G Fine, D. Gareth Evans, Anthony Howell, Penelope Hopwood, Phillip Görden, David B. Savage, Elaine Cochran, Taylor Salinardi, David Araújo‐Vilar and Rebecca J. Brown and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Alison Long

18 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Long United States 11 293 241 190 111 75 19 624
Fabienne Gumy‐Pause Switzerland 16 28 0.1× 238 1.0× 137 0.7× 85 0.8× 31 0.4× 44 677
Seung Taik Kim South Korea 15 44 0.2× 125 0.5× 182 1.0× 51 0.5× 40 0.5× 29 588
Nathan Schoettler United States 11 92 0.3× 165 0.7× 52 0.3× 42 0.4× 392 5.2× 18 753
Shubhada Jagasia United States 11 76 0.3× 85 0.4× 64 0.3× 118 1.1× 21 0.3× 21 486
William R. Kiffmeyer United States 8 28 0.1× 174 0.7× 75 0.4× 96 0.9× 17 0.2× 9 446
I J Lewis United Kingdom 14 40 0.1× 92 0.4× 142 0.7× 18 0.2× 33 0.4× 23 545
Reyad Abbadi United Kingdom 9 69 0.2× 217 0.9× 60 0.3× 18 0.2× 38 0.5× 19 407
Irène Feroce Italy 12 244 0.8× 152 0.6× 119 0.6× 3 0.0× 25 0.3× 33 521
Wenndy Hernandez United States 12 205 0.7× 137 0.6× 77 0.4× 26 0.2× 10 0.1× 17 494
Vladimı́r Vašků Czechia 12 22 0.1× 57 0.2× 38 0.2× 36 0.3× 128 1.7× 50 418

Countries citing papers authored by Alison Long

Since Specialization
Citations

This map shows the geographic impact of Alison Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Long more than expected).

Fields of papers citing papers by Alison Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Long. The network helps show where Alison Long may publish in the future.

Co-authorship network of co-authors of Alison Long

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Long. A scholar is included among the top collaborators of Alison Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Long. Alison Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hughes, Derralynn, et al.. (2022). Design of GALILEO-1, a phase 1/2 safety and efficacy study of FLT201 in adult patients with Gaucher disease type 1. Molecular Genetics and Metabolism. 135(2). S57–S58.
2.
Chowdary, Pratima, Susan Shapiro, Michael Makris, et al.. (2022). Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B. New England Journal of Medicine. 387(3). 237–247. 94 indexed citations
3.
4.
Oral, Elif A, Phillip Görden, Elaine Cochran, et al.. (2019). Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy. Endocrine. 64(3). 500–511. 71 indexed citations
5.
Drygalski, Annette von, Adam Giermasz, Giancarlo Castaman, et al.. (2019). Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Advances. 3(21). 3241–3247. 96 indexed citations
6.
Pipe, Steven W., Adam Giermasz, Giancarlo Castaman, et al.. (2019). One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B. Blood. 134(Supplement_1). 3348–3348. 11 indexed citations
7.
8.
Brown, Rebecca J., Elif A Oral, Elaine Cochran, et al.. (2018). Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine. 60(3). 479–489. 103 indexed citations
9.
DePaoli, Alex M., Alison Long, G Fine, Murray Stewart, & Stephen O’Rahilly. (2018). Efficacy of Metreleptin for Weight Loss in Overweight and Obese Adults with Low Leptin Levels. Diabetes. 67(Supplement_1). 21 indexed citations
10.
Schultes, Birgit C., Chia Lin Chu, Alison Long, et al.. (2014). The effect and mechanism of M402 on gemcitabine uptake into pancreatic tumors.. Journal of Clinical Oncology. 32(3_suppl). 215–215. 2 indexed citations
11.
Schultes, Birgit C., Martijn P. Lolkema, Chia Lin Chu, et al.. (2012). M402, a heparan sulfate mimetic and novel candidate for the treatment of pancreatic cancer.. Journal of Clinical Oncology. 30(15_suppl). 4056–4056. 3 indexed citations
12.
Galcheva-Gargova, Zoya, et al.. (2012). Role of M402, a novel heparan sulfate mimetic, in pancreatic cancer cell invasion and metastasis: Inhibition of the Sonic Hedgehog pathway and heparanase activity.. Journal of Clinical Oncology. 30(30_suppl). 25–25. 4 indexed citations
13.
Chu, Chia Lin, Alison Long, Jay Duffner, et al.. (2012). Abstract 1524: M402, a novel heparan sulfate mimetic, inhibits pancreatic tumor growth and desmoplasia potentially via sonic hedgehog signaling in an orthotopic mouse model. Cancer Research. 72(8_Supplement). 1524–1524. 1 indexed citations
14.
Long, Alison, Ishan Capila, Ram Sasisekharan, et al.. (2009). M118 – A rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes. Thrombosis and Haemostasis. 102(11). 900–906. 10 indexed citations
15.
Goldstein, Neal S., Alison Long, Shih–Fan Kuan, & John Hart. (2000). Colon Signet Ring Cell Adenocarcinoma: Immunohistochemical Characterization and Comparison with Gastric and Typical Colon Adenocarcinomas. Applied immunohistochemistry & molecular morphology. 8(3). 183–188. 57 indexed citations
16.
Goldstein, Neal S., Alison Long, Shih–Fan Kuan, & John Hart. (2000). . Applied Immunohistochemistry. 8(3). 183–188. 14 indexed citations
17.
Hopwood, Penelope, et al.. (1998). Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology. 7(5). 402–412. 105 indexed citations
18.
Hopwood, Penelope, et al.. (1998). Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology. 7(5). 402–412. 13 indexed citations
19.
Afdhal, Nezam H., et al.. (1987). Immunohistochemical Cal9-9 in primary colonic polyps and polyps synchronous with colorectal cancer.. Gut. 28(5). 594–600. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabienne Gumy‐Pause Breakdown of academic impact, for papers by Seung Taik Kim Breakdown of academic impact, for papers by Nathan Schoettler Breakdown of academic impact, for papers by Shubhada Jagasia Breakdown of academic impact, for papers by William R. Kiffmeyer Breakdown of academic impact, for papers by I J Lewis Breakdown of academic impact, for papers by Reyad Abbadi Breakdown of academic impact, for papers by Irène Feroce Breakdown of academic impact, for papers by Wenndy Hernandez Breakdown of academic impact, for papers by Vladimı́r Vašků
Rankless by CCL
2026